| 10-10-2012 08:14 PM CET - Health & Medicine |
|
SMi’s 4th annual COPD: Novel therapeutics and Management Strategies conference
Press release from: SMi Group
SMi’s 4th annual COPD: Novel Therapeutics & Management Strategies conference held on the 22nd & 23rd October in London will address therapeutic and management strategies for COPD with an international mix of key opinion leaders in this ever expanding field. It will also provide a comprehensive overview of successful clinical trial design and exacerbation management methods alongside identifying novel targets for COPD therapy, thus paving the way for COPD management and exacerbation prevention.
SMi is pleased to confirm Emma Baker, Professor of Clinical Pharmacology, St. George’s University of London to speak at the upcoming event
Professor Baker will be presenting on the effective management of COPD, what are the burdens to society, the patient and to the economy, computer guided diagnosis and treatment algorithms and lessons from Asthma that we can use in COPD.
This prestigious conference will be an industry-led event which will also encompass presentations from academic keynotes who aim to provide an unmatched forum for discussion and debate into pulmonary rehabilitation, novel COPD management strategies and innovative therapeutic developments. Attending will enable you to
Evaluate the benefits of anti-inflammatory drugs, alongside potential biological targets for therapeutic interventions in COPD
Compare and contrast diverse responses in COPD immunology
Hear from industry professionals on computer guided diagnosis and treatment algorithms
Assess co-morbidities in COPD and their relevance in pharmaceutical studies
Identify effective pharmacological interventions for the reduction of exacerbation frequency
Discuss the most relevant outcome parameters in COPD clinical trials
For more information visit contact Farhaana Rahman on tel. +44 0207 827 6186 or email frahman@smi-online.co.uk
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
SMi Group Ltd
2nd Floor South, Harling House
47-51 Great Suffolk Street,
London, SE1 0BS
This release was published on openPR.
SMi is pleased to confirm Emma Baker, Professor of Clinical Pharmacology, St. George’s University of London to speak at the upcoming event
Professor Baker will be presenting on the effective management of COPD, what are the burdens to society, the patient and to the economy, computer guided diagnosis and treatment algorithms and lessons from Asthma that we can use in COPD.
This prestigious conference will be an industry-led event which will also encompass presentations from academic keynotes who aim to provide an unmatched forum for discussion and debate into pulmonary rehabilitation, novel COPD management strategies and innovative therapeutic developments. Attending will enable you to
Evaluate the benefits of anti-inflammatory drugs, alongside potential biological targets for therapeutic interventions in COPD
Compare and contrast diverse responses in COPD immunology
Hear from industry professionals on computer guided diagnosis and treatment algorithms
Assess co-morbidities in COPD and their relevance in pharmaceutical studies
Identify effective pharmacological interventions for the reduction of exacerbation frequency
Discuss the most relevant outcome parameters in COPD clinical trials
For more information visit contact Farhaana Rahman on tel. +44 0207 827 6186 or email frahman@smi-online.co.uk
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
SMi Group Ltd
2nd Floor South, Harling House
47-51 Great Suffolk Street,
London, SE1 0BS
This release was published on openPR.
News-ID: 239268
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
SMi Group
Comments about openPR
OpenPR is clearly structured and remains true to its principle of confining itself to the essential parts.
OpenPR has proven to be a very good and reliable partner to our media agency:
Within the shortest time the releases are online and go down well with the media representatives.
The success of OpenPR is reflected in the steadily increasing number of press releases.
It is good that OpenPR exists!
Ursula Koslik,Director Marketing & PR, F+W Hamburg
OpenPR has proven to be a very good and reliable partner to our media agency:
Within the shortest time the releases are online and go down well with the media representatives.
The success of OpenPR is reflected in the steadily increasing number of press releases.
It is good that OpenPR exists!
Ursula Koslik,Director Marketing & PR, F+W Hamburg


